US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist

16.370
+0.190+1.17%

Close Nov 22 16:00 ET

16.400
+0.030+0.18%

Post 20:01 ET

2.72BMarket Cap20.99P/E (TTM)

ACADIA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

207.28%63.25M

205.00%25.01M

262.15%29.08M

114.65%16.7M

457.97%85.39M

-8,009.35%-58.96M

162.48%8.2M

76.51%-17.93M

9.25%-114.04M

-3.17%-23.85M

Net income from continuing operations

150.27%32.77M

2,897.22%33.39M

138.48%16.56M

71.62%-61.29M

209.76%45.8M

-139.77%-65.18M

103.28%1.11M

61.95%-43.02M

-28.66%-215.98M

3.18%-41.73M

Operating gains losses

----

-29.45%-4.59M

--0

30.94%-1.49M

150.30%1.24M

-1,180.24%-4.34M

-52.08%-3.54M

4.87%-1.54M

Depreciation and amortization

49.16%2.57M

45.58%2.57M

1,197.65%5.53M

174.04%5.55M

234.76%1.64M

240.51%1.72M

242.91%1.77M

-17.44%426K

-39.41%2.03M

-8.60%489K

Change In working capital

142.57%4.49M

-157.44%-24.68M

-136.03%-5.97M

-52.27%18.13M

228.66%21.71M

-196.11%-10.56M

-1,198.92%-9.59M

-21.65%16.56M

253.04%37.99M

-12.43%6.61M

-Change in receivables

100.29%30K

25.83%-10.31M

131.67%2.27M

-1,834.54%-39.27M

-12.59%-7.82M

-181.36%-10.38M

-157.19%-13.91M

-485.07%-7.17M

115.03%2.26M

-88.90%-6.94M

-Change in inventory

88.14%-1.33M

-804.90%-27.15M

-3,561.12%-16.65M

-1,292.88%-28.81M

-4,960.32%-15.07M

-1,853.44%-11.22M

-574.68%-3M

-42.26%481K

157.36%2.42M

42.86%310K

-Change in prepaid assets

60.91%-5.49M

-1,152.85%-3.3M

-64.28%-3.67M

-809.42%-17.69M

-171.54%-1.14M

-588.63%-14.06M

-105.48%-263K

-19.91%-2.23M

38.40%2.49M

118.49%1.6M

-Change in payables and accrued expense

-42.56%12.44M

310.23%15.4M

-52.09%13.98M

224.65%97.97M

367.66%43.37M

2,431.65%21.66M

316.74%3.75M

23.86%29.19M

399.60%30.18M

16.51%9.27M

-Change in other current assets

-6.74%1.59M

20.84%1.89M

1.91%1.76M

-12.00%5.74M

-57.06%739K

5.05%1.71M

-5.21%1.56M

13.40%1.73M

3.51%6.52M

15.35%1.72M

-Change in other current liabilities

-258.70%-2.74M

-153.51%-1.21M

32.50%-3.66M

103.42%201K

150.69%1.63M

262.35%1.73M

431.14%2.27M

-13.54%-5.43M

-64.18%-5.88M

-20.80%651K

Cash from discontinued investing activities

Operating cash flow

207.28%63.25M

205.00%25.01M

262.15%29.08M

114.65%16.7M

457.97%85.39M

-8,009.35%-58.96M

162.48%8.2M

76.51%-17.93M

9.25%-114.04M

-3.17%-23.85M

Investing cash flow

Cash flow from continuing investing activities

-341.74%-82.46M

71.08%-56.19M

-107.29%-14.04M

-56.31%32M

98.04%-347K

120.91%34.11M

-248.20%-194.28M

46.57%192.52M

203.01%73.24M

-124.81%-17.75M

Net PPE purchase and sale

----

---50K

--0

----

--0

Net intangibles purchase and sale

--0

----

---40M

--0

----

--0

Net investment purchase and sale

-341.18%-82.39M

63.58%-56.19M

-107.29%-14.04M

-1.63%72.05M

98.04%-347K

121.23%34.16M

-176.51%-154.28M

46.57%192.52M

204.66%73.24M

-124.81%-17.75M

Cash from discontinued investing activities

Investing cash flow

-341.74%-82.46M

71.08%-56.19M

-107.29%-14.04M

-56.31%32M

98.04%-347K

120.91%34.11M

-248.20%-194.28M

46.57%192.52M

203.01%73.24M

-124.81%-17.75M

Financing cash flow

Cash flow from continuing financing activities

-97.90%268K

-34.92%3.57M

-28.85%1.04M

206.49%25.13M

236.68%5.43M

4,342.86%12.75M

42.99%5.48M

-40.58%1.47M

-54.86%8.2M

-63.02%1.61M

Net common stock issuance

-97.90%268K

-34.92%3.57M

-28.85%1.04M

206.49%25.13M

236.68%5.43M

4,342.86%12.75M

42.99%5.48M

-40.58%1.47M

-54.86%8.2M

-63.02%1.61M

Cash from discontinued financing activities

Financing cash flow

-97.90%268K

-34.92%3.57M

-28.85%1.04M

206.49%25.13M

236.68%5.43M

4,342.86%12.75M

42.99%5.48M

-40.58%1.47M

-54.86%8.2M

-63.02%1.61M

Net cash flow

Beginning cash position

57.59%182.9M

-29.04%210.52M

61.20%194.43M

-21.27%120.62M

-35.27%103.96M

-20.29%116.06M

40.81%296.67M

-21.27%120.62M

-53.83%153.21M

59.96%160.61M

Current changes in cash

-56.63%-18.94M

84.71%-27.61M

-90.86%16.08M

326.50%73.83M

326.26%90.48M

-180.62%-12.09M

-177.46%-180.6M

206.27%176.05M

81.75%-32.6M

-175.74%-39.99M

Effect of exchange rate changes

-950.00%-42K

--3K

350.00%5K

-400.00%-18K

-50.00%-12K

-150.00%-4K

--0

-200.00%-2K

-14.29%6K

-900.00%-8K

End cash Position

57.67%163.92M

57.59%182.9M

-29.04%210.52M

61.20%194.43M

-35.27%103.96M

-20.29%116.06M

40.81%296.67M

-21.27%120.62M

Free cash flow

207.07%63.18M

178.66%25.01M

262.15%29.08M

79.53%-23.35M

457.97%85.39M

-8,016.23%-59.01M

-142.28%-31.8M

76.51%-17.93M

10.05%-114.04M

-3.17%-23.85M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	207.28%63.25M	205.00%25.01M	262.15%29.08M	114.65%16.7M	457.97%85.39M	-8,009.35%-58.96M	162.48%8.2M	76.51%-17.93M	9.25%-114.04M	-3.17%-23.85M
Net income from continuing operations	150.27%32.77M	2,897.22%33.39M	138.48%16.56M	71.62%-61.29M	209.76%45.8M	-139.77%-65.18M	103.28%1.11M	61.95%-43.02M	-28.66%-215.98M	3.18%-41.73M
Operating gains losses	----	----	----	-29.45%-4.59M	--0	30.94%-1.49M	150.30%1.24M	-1,180.24%-4.34M	-52.08%-3.54M	4.87%-1.54M
Depreciation and amortization	49.16%2.57M	45.58%2.57M	1,197.65%5.53M	174.04%5.55M	234.76%1.64M	240.51%1.72M	242.91%1.77M	-17.44%426K	-39.41%2.03M	-8.60%489K
Change In working capital	142.57%4.49M	-157.44%-24.68M	-136.03%-5.97M	-52.27%18.13M	228.66%21.71M	-196.11%-10.56M	-1,198.92%-9.59M	-21.65%16.56M	253.04%37.99M	-12.43%6.61M
-Change in receivables	100.29%30K	25.83%-10.31M	131.67%2.27M	-1,834.54%-39.27M	-12.59%-7.82M	-181.36%-10.38M	-157.19%-13.91M	-485.07%-7.17M	115.03%2.26M	-88.90%-6.94M
-Change in inventory	88.14%-1.33M	-804.90%-27.15M	-3,561.12%-16.65M	-1,292.88%-28.81M	-4,960.32%-15.07M	-1,853.44%-11.22M	-574.68%-3M	-42.26%481K	157.36%2.42M	42.86%310K
-Change in prepaid assets	60.91%-5.49M	-1,152.85%-3.3M	-64.28%-3.67M	-809.42%-17.69M	-171.54%-1.14M	-588.63%-14.06M	-105.48%-263K	-19.91%-2.23M	38.40%2.49M	118.49%1.6M
-Change in payables and accrued expense	-42.56%12.44M	310.23%15.4M	-52.09%13.98M	224.65%97.97M	367.66%43.37M	2,431.65%21.66M	316.74%3.75M	23.86%29.19M	399.60%30.18M	16.51%9.27M
-Change in other current assets	-6.74%1.59M	20.84%1.89M	1.91%1.76M	-12.00%5.74M	-57.06%739K	5.05%1.71M	-5.21%1.56M	13.40%1.73M	3.51%6.52M	15.35%1.72M
-Change in other current liabilities	-258.70%-2.74M	-153.51%-1.21M	32.50%-3.66M	103.42%201K	150.69%1.63M	262.35%1.73M	431.14%2.27M	-13.54%-5.43M	-64.18%-5.88M	-20.80%651K
Cash from discontinued investing activities
Operating cash flow	207.28%63.25M	205.00%25.01M	262.15%29.08M	114.65%16.7M	457.97%85.39M	-8,009.35%-58.96M	162.48%8.2M	76.51%-17.93M	9.25%-114.04M	-3.17%-23.85M
Investing cash flow
Cash flow from continuing investing activities	-341.74%-82.46M	71.08%-56.19M	-107.29%-14.04M	-56.31%32M	98.04%-347K	120.91%34.11M	-248.20%-194.28M	46.57%192.52M	203.01%73.24M	-124.81%-17.75M
Net PPE purchase and sale	----	----	----	---50K	--0	----	----	----	--0	--0
Net intangibles purchase and sale	--0	----	----	---40M	--0	--0	----	----	--0	--0
Net investment purchase and sale	-341.18%-82.39M	63.58%-56.19M	-107.29%-14.04M	-1.63%72.05M	98.04%-347K	121.23%34.16M	-176.51%-154.28M	46.57%192.52M	204.66%73.24M	-124.81%-17.75M
Cash from discontinued investing activities
Investing cash flow	-341.74%-82.46M	71.08%-56.19M	-107.29%-14.04M	-56.31%32M	98.04%-347K	120.91%34.11M	-248.20%-194.28M	46.57%192.52M	203.01%73.24M	-124.81%-17.75M
Financing cash flow
Cash flow from continuing financing activities	-97.90%268K	-34.92%3.57M	-28.85%1.04M	206.49%25.13M	236.68%5.43M	4,342.86%12.75M	42.99%5.48M	-40.58%1.47M	-54.86%8.2M	-63.02%1.61M
Net common stock issuance	-97.90%268K	-34.92%3.57M	-28.85%1.04M	206.49%25.13M	236.68%5.43M	4,342.86%12.75M	42.99%5.48M	-40.58%1.47M	-54.86%8.2M	-63.02%1.61M
Cash from discontinued financing activities
Financing cash flow	-97.90%268K	-34.92%3.57M	-28.85%1.04M	206.49%25.13M	236.68%5.43M	4,342.86%12.75M	42.99%5.48M	-40.58%1.47M	-54.86%8.2M	-63.02%1.61M
Net cash flow
Beginning cash position	57.59%182.9M	-29.04%210.52M	61.20%194.43M	-21.27%120.62M	-35.27%103.96M	-20.29%116.06M	40.81%296.67M	-21.27%120.62M	-53.83%153.21M	59.96%160.61M
Current changes in cash	-56.63%-18.94M	84.71%-27.61M	-90.86%16.08M	326.50%73.83M	326.26%90.48M	-180.62%-12.09M	-177.46%-180.6M	206.27%176.05M	81.75%-32.6M	-175.74%-39.99M
Effect of exchange rate changes	-950.00%-42K	--3K	350.00%5K	-400.00%-18K	-50.00%-12K	-150.00%-4K	--0	-200.00%-2K	-14.29%6K	-900.00%-8K
End cash Position	57.67%163.92M	57.59%182.9M	-29.04%210.52M	61.20%194.43M	61.20%194.43M	-35.27%103.96M	-20.29%116.06M	40.81%296.67M	-21.27%120.62M	-21.27%120.62M
Free cash flow	207.07%63.18M	178.66%25.01M	262.15%29.08M	79.53%-23.35M	457.97%85.39M	-8,016.23%-59.01M	-142.28%-31.8M	76.51%-17.93M	10.05%-114.04M	-3.17%-23.85M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data